New improved COVID-19 test with superior performance.

Read more

mariPOC® test system

mariPOC® test system enables fast and accurate diagnosis in acute infections. Multiple pathogens are tested from a single clinical sample simultaneously. The fully automated test system enables central laboratory sensitivity and specificity in rapid and decentralized testing. The quality of the results is ensured by a unique internal autoverification system. These together with ease of use make mariPOC® perfectly suitable also for point-of-care testing (POCT).

News

4.3.2021

Press release: ArcDia launches a quick and automated COVID-19 antigen test with superior performance

Turku, Finland, March 3rd, 2021 – the Finnish medical device manufacturer ArcDia International Ltd has...

10.9.2020

Press release: Bruker to distribute ArcDia’s mariPOC® products for automated antigen POCT of COVID-19 and other infectious diseases in Central Europe

Turku, September 10th 2020 – ArcDia International Oy Ltd (“ArcDia”), developer and manufacturer of the...

25.5.2020

Press release: ArcDia Ltd’s automated coronavirus point-of-care test CE marked and available

Turku Finland, May 25, 2020 – the Finnish medical device manufacturer ArcDia International Ltd has...

Events

13.4. - 16.4.2019

ECCMID 2019, Amsterdam, Netherlands

You are invited to visit booth 1.7f and meet mariPOC® team! At our booth you...

21.4. - 24.4.2018

ECCMID 2018, Madrid, Spain

Welcome to experience our exciting mariPOC® booth #100 in ECCMID 2018, Madrid, Spain, April 21st...

8.3. - 9.3.2018

Finnish Virology days

mariPOC is present in Finnish Virology days in Tuusula, Finland. Welcome to have a chat...